Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HACCP

This article was originally published in The Tan Sheet

Executive Summary

Development of Hazard Analysis and Critical Control Points for dietary supplement companies urged by clients of D.C.-based law firm Emord & Associates, who say FDA's proposed GMP standards for supplements would economically harm small businesses by substantially raising production costs without increasing safety and quality. The plaintiffs in the Pearson v. Shalala case say the agency lacks a sufficient scientific basis upon which to ground GMPs for the entire industry and supplement companies are in the best position to identify their own production risks and appropriate countermeasures
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS090279

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel